Case File №
#VI-2026-0520
Hebei Chengtong Technology
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
43 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | X Unrated | 1 | 6.5 | 6.5 | 6.5 | 25 May 2026 |
| 17a-Methyl-1-Testosterone | X N/A | 1 | 4.0 | 1.9 | 1.9 | 28 Mar 2025 |
| 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Apr 2025 |
| AA Water | X N/A | 1 | 4.0 | 3.8 | 3.8 | 20 Jun 2025 |
| ACE-031 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 11 Jun 2025 |
| Adipotide | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Apr 2025 |
| ARA-290 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| Aromasin (Exemestane) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| BAM15 | X N/A | 1 | 4.0 | 1.3 | 1.3 | 2 Jul 2025 |
| BPC-157 Arg Oral | X N/A | 1 | 4.0 | 2.0 | 2.0 | 3 Jun 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| Cerebrolysin | X N/A | 1 | 4.0 | 0.0 | 0.0 | 27 Feb 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 4.0 | 0.5 | 0.5 | 16 Mar 2025 |
| Dapoxetine | X N/A | 1 | 4.0 | 0.0 | 0.0 | 28 Mar 2025 |
| DHB (1-Test Cyp) Oral | X N/A | 1 | 4.0 | 0.0 | 0.0 | 11 Jun 2025 |
| DSIP | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Jul 2025 |
| Equipoise (Boldenone Undecylenate) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 7 May 2025 |
| Halotestin (Fluoxymesterone) | X N/A | 1 | 4.0 | 1.8 | 1.8 | 25 Apr 2025 |
| HMG | X N/A | 1 | 4.0 | 1.1 | 1.1 | 2 Apr 2025 |
| Humanin | X N/A | 1 | 4.0 | 0.3 | 0.3 | 2 Apr 2025 |
| Hyaluronic acid | X N/A | 1 | 4.0 | 0.0 | 0.0 | 8 Jul 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
| KPV | X N/A | 1 | 4.0 | 1.4 | 1.4 | 7 May 2025 |
| Letrozole | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Jun 2025 |
| MOTS-C | X N/A | 1 | 4.0 | 0.1 | 0.1 | 2 Jul 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 8 Jul 2025 |
| NAD+ Injectable | X N/A | 1 | 4.0 | 1.7 | 1.7 | 16 Mar 2025 |
| P21 | X N/A | 1 | 4.0 | 0.4 | 0.4 | 17 Dec 2024 |
| Phenylacetic acid CAS 103-82-2 | X N/A | 1 | 4.0 | 2.0 | 2.0 | 24 Apr 2025 |
| Pinealon | X N/A | 1 | 4.0 | 0.1 | 0.1 | 2 Apr 2025 |
| Prostamax | X N/A | 1 | 4.0 | 0.0 | 0.0 | 11 Jun 2025 |
| PTD-DBM | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Jun 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 4.0 | 0.0 | 0.0 | 11 Jun 2025 |
| S-23 Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 9 Jun 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| Selank | X N/A | 1 | 4.0 | 0.7 | 0.7 | 13 Jun 2025 |
| SS-31 (Elamipretide) Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 11 Jun 2025 |
| Superdrol | X N/A | 1 | 4.0 | 1.1 | 1.1 | 24 Apr 2025 |
| Testosterone Base Micro Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 25 Apr 2025 |
| Testosterone Cypionate Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 7 May 2025 |
| Testosterone Phenylpropionate Raw | X N/A | 1 | 4.0 | 0.1 | 0.1 | 14 Jan 2025 |
| Testosterone Propionate Raw | X N/A | 1 | 4.0 | 2.3 | 2.3 | 3 Jul 2025 |
| Turinabol | X N/A | 1 | 4.0 | 0.7 | 0.7 | 14 Jan 2025 |
Exhibit II
Evidence Log
42 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | KPV | 4.0 C | 20mg | 22.7mg | +13.6% | 99.09% | x49hz9 | Lab F | Public |
| 25 May 2026 | P21 | 5.3 B | 30mg | 29.3mg | -2.3% | 98.70% | rj6h28 | Lab D | Community |
| 25 May 2026 | Prostamax | 4.4 C | 2mg | 2.3mg | +16.2% | 99.36% | 9g0dm0 | Lab A | Community |
| 24 May 2026 | Equipoise (Boldenone Undecylenate) | 4.0 C | 200mg/ml | 217.6mg/ml | +8.8% | 97.04% | r5njs2 | Lab G | Public |
| 24 May 2026 | HMG | 4.0 C | 50mg | 49.6mg | -0.7% | 96.95% | rjaqlp | Lab C | Public |
| 24 May 2026 | Letrozole | 5.9 B | 50mg | 51.3mg | +2.6% | 98.65% | lrpqtu | Lab B | Community |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.0 C | 20mg | 22.7mg | +13.5% | 97.79% | 7szn1x | Lab G | Community |
| 24 May 2026 | Halotestin (Fluoxymesterone) | 4.0 C | 25mg | 30.2mg | +20.8% | 95.06% | byoima | Lab A | Public |
| 24 May 2026 | Pinealon | 4.6 C | 10mg | 10.3mg | +3.0% | 99.58% | 1fef7t | Lab E | Community |
| 24 May 2026 | PTD-DBM | 5.5 B | 15mg | 18.7mg | +24.8% | 95.18% | wdwuz0 | Lab D | Community |
| 23 May 2026 | DSIP | 4.6 C | 50mg | 48.3mg | -3.4% | 96.08% | nkffju | Lab C | Public |
| 23 May 2026 | MOTS-C | 4.7 C | 30mg | 33.8mg | +12.8% | 98.45% | f4knfk | Lab F | Community |
| 23 May 2026 | Superdrol | 5.5 B | 20mg | 19.7mg | -1.3% | 99.94% | 8ltgua | Lab D | Public |
| 23 May 2026 | S-23 Raw | 4.0 C | 10g | 8.9g | -10.5% | 98.68% | kjx9h8 | Lab A | Public |
| 21 May 2026 | AA Water | 4.1 C | 30mg | 31.8mg | +6.0% | 98.25% | zzipq9 | Lab E | Community |
| 21 May 2026 | Aromasin (Exemestane) | 4.8 C | 20mg | 22.5mg | +12.3% | 96.52% | 3hjnrd | Lab D | Public |
| 20 May 2026 | Phenylacetic acid CAS 103-82-2 | 5.3 B | 5g | 5.8g | +15.1% | 97.08% | 5c4le8 | Lab B | Public |
| 20 May 2026 | Testosterone Base Micro Raw | 4.1 C | 100g | 98.5g | -1.5% | 97.60% | n1458k | Lab G | Community |
| 26 Jan 2026 | Testosterone Cypionate Raw | 4.8 C | 1g | 0.9g | -6.0% | 96.29% | ss4bai | Lab E | Community |
| 19 Jan 2026 | Humanin | 4.0 C | 30mg | 32.7mg | +9.2% | 95.43% | 8v0lnt | Lab D | Public |
| 9 Jan 2026 | Adipotide | 4.0 C | 2mg | 2.2mg | +10.3% | 99.81% | tz1ui8 | Lab F | Public |
| 9 Jan 2026 | BAM15 | 4.1 C | 50mg | 45.4mg | -9.3% | 97.62% | by5119 | Lab A | Public |
| 7 Jan 2026 | ACE-031 | 4.3 C | 10mg | 10.4mg | +4.1% | 97.98% | zn2vn6 | Lab F | Public |
| 6 Jan 2026 | ARA-290 | 4.0 C | 30mg | 29.9mg | -0.3% | 99.50% | cdwpyc | Lab F | Public |
| 6 Jan 2026 | Dapoxetine | 5.5 B | 25mg | 31.2mg | +24.8% | 96.57% | 7fih4w | Lab B | Public |
| 6 Jan 2026 | Testosterone Propionate Raw | 4.3 C | 10g | 10.1g | +0.5% | 96.18% | t4d8u9 | Lab F | Public |
| 29 Dec 2025 | DHB (1-Test Cyp) Oral | 4.0 C | 25mg | 24.9mg | -0.6% | 97.24% | y8nvgl | Lab C | Public |
| 29 Dec 2025 | NAD+ Injectable | 4.0 C | 200mg/ml | 222.2mg/ml | +11.1% | 95.49% | ysvnuw | Lab E | Community |
| 29 Dec 2025 | Retatrutide 30mg Pen Kit | 4.2 C | 20mg | 17.4mg | -13.1% | 97.50% | hwdzau | Lab G | Public |
| 29 Dec 2025 | Selank 10mg + Semax 10mg Blend | 4.6 C | 2mg | 1.8mg | -7.8% | 95.02% | woklih | Lab E | Public |
| 12 Dec 2025 | Turinabol | 4.3 C | 10mg | 11.0mg | +10.1% | 96.08% | tm719t | Lab C | Public |
| 5 Dec 2025 | 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | 4.0 C | 1g | 0.9g | -11.0% | 97.95% | xd6up4 | Lab F | Community |
| 23 Nov 2025 | BPC-157 Arg Oral | 4.0 C | 100mg | 108.7mg | +8.7% | 99.34% | 20be5v | Lab F | Public |
| 23 Nov 2025 | Hyaluronic acid | 5.8 B | 10mg | 9.7mg | -3.0% | 96.82% | k8n516 | Lab D | Public |
| 23 Nov 2025 | Selank | 4.0 C | 5mg | 6.0mg | +19.1% | 98.70% | 0wbvof | Lab F | Public |
| 17 Nov 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 4.8 C | 20mg | 21.0mg | +4.8% | 98.93% | 72lm8x | Lab E | Public |
| 17 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.0 C | 50mg | 57.0mg | +13.9% | 99.60% | dw87xz | Lab E | Community |
| 5 Nov 2025 | 17a-Methyl-1-Testosterone | 5.0 B | 100mg | 92.7mg | -7.3% | 99.88% | c9k7oc | Lab E | Public |
| 5 Nov 2025 | Cerebrolysin | 4.0 C | 30mg | 28.9mg | -3.8% | 99.59% | nls94h | Lab A | Community |
| 4 Nov 2025 | SS-31 (Elamipretide) Raw | 4.2 C | 500g | 583.9g | +16.8% | 96.07% | jxyoy3 | Lab B | Community |
| 17 Oct 2025 | Testosterone Phenylpropionate Raw | 4.4 C | 5g | 5.1g | +1.8% | 98.49% | sih4it | Lab E | Community |
| 9 Oct 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 4.0 C | 50mg | 46.0mg | -7.9% | 99.62% | c6pjjl | Lab B | Public |
— END OF EVIDENCE LOG —